![Dominick DiPaolo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dominick DiPaolo
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Dominick DiPaolo
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dominick DiPaolo
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Reliant Pharmaceuticals LLC
![]() Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Carigent Therapeutics, Inc.
![]() Carigent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carigent Therapeutics, Inc. develops pharmaceutical products. The firm delivers drugs and provides development and commercialization of innovative medical treatments. The company was founded by W. Mark Saltzman in January 26, 2007 and is headquartered in New Haven, CT. | Pharmaceuticals: Major | President | |
Omthera Pharmaceuticals, Inc.
![]() Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Matinas BioPharma, Inc. | Director/Board Member Founder | ||
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
Ortho-McNeil Pharmaceutical LLC
![]() Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Franklin & Marshall College | College/University | Undergraduate Degree | |
University of San Francisco | College/University | Undergraduate Degree | |
Ikonisys, Inc.
![]() Ikonisys, Inc. Medical SpecialtiesHealth Technology Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT. | Medical Specialties | Director/Board Member | |
US Food & Drug Administration
![]() US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
MPEX Pharmaceuticals, Inc.
![]() MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Prime Acquisition, Inc.
![]() Prime Acquisition, Inc. Miscellaneous Commercial ServicesCommercial Services Prime Acquisition, Inc. is based in Rhinebeck, NY. Stefano Ferrari has been the CEO of the company since 2013. Part of NeuBase Therapeutics, Inc., Prime Acquisition, Inc. is an acquisition vehicle. | Miscellaneous Commercial Services | Chief Executive Officer | |
Clinical & Laboratory Standards Institute, Inc. (Pennsylvania)
![]() Clinical & Laboratory Standards Institute, Inc. (Pennsylvania) Miscellaneous Commercial ServicesCommercial Services Clinical & Laboratory Standards Institute is a non profit organization which develops clinical and laboratory practices and promoting their use worldwide. it offers education, membership, and specialty areas which include general laboratory, newborn screening, clinical chemistry and toxicology, hematology, and quality management systems. The company was founded in 1968 and is headquartered in Wayne, PA. | Miscellaneous Commercial Services | Director/Board Member | |
Logistics & Environmental Solutions Corp.
![]() Logistics & Environmental Solutions Corp. Air Freight/CouriersTransportation Logistics & Environmental Solutions Corp. provides logistics solutions for government and commercial markets. It services include engineering, maintenance support, professional support, human resources, warehousing, and distribution services. The company was founded in 1992 and is headquartered in Huntsville, AL. | Air Freight/Couriers | Sales & Marketing | |
Knoll Pharmaceutical Co. | Corporate Officer/Principal | ||
Trygg Pharma AS
![]() Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Trygg Pharma AS develops marine based omega-3 fatty acids for pharmaceutical applications. Its products consist of AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters; and AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters. The company was founded in 2009 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Wageningen University | College/University | Undergraduate Degree | |
Bioseutica B.V.
![]() Bioseutica B.V. Chemicals: Major DiversifiedProcess Industries Bioseutica B.V. manufactures proteins for the food, feed, and pharmaceutical sectors. The private company is based in Lugano, Switzerland, and has subsidiaries in Belgium. | Chemicals: Major Diversified | Chief Executive Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Kellogg School of Management | College/University | Masters Business Admin | |
Rutgers Business School | College/University | Masters Business Admin | |
Essential Fatty Acid Therapeutics LLC | Founder | ||
Temple University School of Medicine | College/University | Doctorate Degree | |
Shionogi USA Holdings, Inc. | Corporate Officer/Principal | ||
Corvidia Therapeutics, Inc.
![]() Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Corporate Officer/Principal | |
Richard B. Fisher Center for the Performing Arts | Director/Board Member | ||
NewAmsterdam Pharma Holding BV
![]() NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Chief Operating Officer | |
IDTD Consulting SASU | Corporate Officer/Principal | ||
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Chief Operating Officer | |
GRI BIO, INC. | Biotechnology | Director/Board Member | |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Chief Operating Officer | |
Chestnut Hill Sciences LLC
![]() Chestnut Hill Sciences LLC Miscellaneous Commercial ServicesCommercial Services Chestnut Hill Sciences LLC provides business services. The private company is based in Rhinebeck, NY. The company was founded by Stefano Ferrari. | Miscellaneous Commercial Services | Founder | |
Murami Pharma, Inc. | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 35 |
Niederlande | 6 |
Norwegen | 2 |
Frankreich | 2 |
Sektoral
Health Technology | 17 |
Consumer Services | 9 |
Commercial Services | 8 |
Government | 2 |
Transportation | 2 |
Operativ
Corporate Officer/Principal | 14 |
Director/Board Member | 12 |
Chief Executive Officer | 8 |
President | 6 |
Undergraduate Degree | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Matthew Wikler | 16 |
Douglas Kling | 12 |
Stefano Ferrari | 10 |
Roelof Rongen | 10 |
- Börse
- Insiders
- Dominick DiPaolo
- Unternehmensverbindungen